Pakitingnan ang buong advisory para sa higit pang impormasyon, kabilang ang kung ano ang dapat gawin ng mga Canadian at ang gawain ng Health Canada upang matugunan ang isyu ng azido impurities na matatagpuan sa ilang partikular na gamot.
produkto | kompanya | Malaking ingay | Marami | Pag-expire |
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389657 | 2005006959 | Abril 2023 |
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389657 | 2005006960 | Abril 2023 |
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389657 | 2005006961 | Abril 2023 |
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389657 | 2005006962 | Abril 2023 |
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389657 | 2005006963 | Abril 2023 |
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389657 | 2005011154 | Hunyo 2023 |
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389657 | 2005011156 | Hunyo 2023 |
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389665 | 2005006807 | Abril 2022 |
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389665 | 2005006808 | Abril 2022 |
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389665 | 2005006809 | Abril 2022 |
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389665 | 2005006810 | Abril 2022 |
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS | Mint Pharmaceuticals Inc. | 02389665 | 2105002149 | Disyembre 2022 |
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 1805012687 | Oktubre 2021 |
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 1805012688 | Oktubre 2021 |
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 1805012689 | Oktubre 2021 |
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 1805012792 | Oktubre 2021 |
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 1905001010 | Disyembre 2021 |
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 1905001011 | Disyembre 2021 |
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2005006947 | Abril 2023 |
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2005006949 | Abril 2023 |
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2005006950 | Abril 2023 |
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2005006951 | Abril 2023 |
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2005007297 | Abril 2023 |
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2005007298 | Abril 2023 |
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2005013776 | Agosto 2023 |
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS | Mint Pharmaceuticals Inc. | 02389673 | 2105002150 | Disyembre 2023 |
ANO ANG DAPAT ALISIN SA ARTIKULONG ITO:
- 023896732005006947April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.
- 023896732005006949April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.
- 023896732005006950April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.